Back to Search

ROBERT ORTMANN, MD

MD

Rheumatology Physician

NPI: 1215987185Individual

Specialties, Licenses & Credentials

Rheumatology PhysicianPrimary

Internal Medicine — Rheumatology

Code: 207RR0500X

2001005641(MO)E-5590(AR)01072827A(IN)

Research & Publications (20)

Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residues.
PMID 17806130·Arch Pharm (Weinheim)·2007
8-other
A heritable defect in IL-12 signaling in B10.Q/J mice. I. In vitro analysis.
PMID 11313413·J Immunol·2001
7-preclinical
Susceptibility to collagen-induced arthritis: cytokine-mediated regulation.
PMID 11141333·Clin Immunol·2001
7-preclinical
Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.
PMID 11094415·Arthritis Res·2000
6-review
Update on cyclophosphamide for systemic lupus erythematosus.
PMID 10768217·Rheum Dis Clin North Am·2000
6-review
Structure-based optimization of aldose reductase inhibitors originating from virtual screening.
PMID 19301313·ChemMedChem·2009
8-other
Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
PMID 18470859·ChemMedChem·2008
7-preclinical
Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
PMID 18470849·ChemMedChem·2008
8-other
Synoviolin promotes IRE1 ubiquitination and degradation in synovial fibroblasts from mice with collagen-induced arthritis.
PMID 18369366·EMBO Rep·2008
7-preclinical
Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates.
PMID 18158249·Bioorg Med Chem·2008
7-preclinical
Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
PMID 17994601·Arch Pharm (Weinheim)·2007
4-observational
Autoimmune vasculitis and plaque erosion in the cardiometabolic syndrome and type 2 diabetes mellitus.
PMID 17679803·J Cardiometab Syndr·2006
5-case
Antimalarial activity of methylpiperazinyl-substituted benzophenone-based farnesyltransferase inhibitors.
PMID 16454209·Pharmazie·2006
7-preclinical
Animal models of rheumatoid arthritis and their relevance to human disease.
PMID 16171986·Pathophysiology·2005
8-other
Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi.
PMID 16279776·J Med Chem·2005
7-preclinical
2-(aminoacylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
PMID 16222868·Pharmazie·2005
7-preclinical
Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
PMID 15996004·Arch Pharm (Weinheim)·2005
7-preclinical
Novel lead structures for antimalarial farnesyltransferase inhibitors.
PMID 15918578·Pharmazie·2005
7-preclinical
Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity.
PMID 15642414·Eur J Med Chem·2005
7-preclinical
2-(Arylpropionylamino)- and 2-(arylacryloylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
PMID 15544051·Pharmazie·2004
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
LILLY CORPORATE CTR, DC 1940
INDIANAPOLIS, IN 46285

Location

Practice Location

LILLY CORPORATE CTR, INDIANAPOLIS, IN
(317) 433-2779

Quick Facts

NPI
1215987185
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
20

Are you this provider?

Claim Your Profile